GLENMARK PHARMACEUTICALS LTD. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

19 Aug 2024

Glenmark Therapeutics Inc., USA launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% (OTC)

Source: BSE India

View all announcements for GLENMARK PHARMACEUTICALS LTD.